Your SlideShare is downloading. ×
0
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

01_Taller SALUD: José Vicente Castell_ISS La Fe

144

Published on

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
144
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
16
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. SINERGIAS ENTRE EL SECTOR SANITARIO (HOSPITALARIO)Y EL EMPRESARIAL JOSEV. CASTELL PHD, MD DIRECTOR
  • 2. UNIVERSITY HOSPITALS : BIOMEDICAL RESEARCH MEDICALTRAINING HEALTHCARE
  • 3. HIGHLY QUALIFIED PERSONNEL + ADVANCED TECHNOLOGIES
  • 4. GREAT INNOVATIVE POTENTIAL … 4
  • 5. Potential ideas / value run out… Clinical care
  • 6. Recovering “energy” : a co-generation model?
  • 7. INNOVATION IN UNIVERSITY HOSPITALS BIOMEDICAL RESEARCH INNOVATION MEDICAL TRAINING HEALTHCARE
  • 8. INTEGRATING INNOVATION IN HOSPITAL ACTIVITY  Innovation is NOT a first priority in hospitals  Innovation should be integrated and be part of the current activity of health professionals  Support structures should be implemented in order to “extract” potential innovations out of clinical knowledge
  • 9. Ideas / biomedical research Strategic Validation Process Prototypes – Proof of concept Integration in healthcare practice Successful INNOVATION is complex Intellectual Property Rights IPRs ClinicalValidation Commercialization Feedback and improvement
  • 10. Idea / biomedical research Strategic Validation Process Prototype – Proof of concept Diffusion and adoption in Healthcare Intellectual Property Rights IPRs ClinicalValidation Commercialization Feedback and improvement Successful INNOVATION is complex
  • 11. The clinical proof of concept/validation Other partners needed?? working with strategic partners
  • 12. Idea Licencing-SME Valorization Commercialization Large investments not always affordable
  • 13. Ideas Licencing-SME Valorization Commercialization “ ”
  • 14.  Linking agents of the Science- technology-Enterprise System, to accelerate the process of valorization, transferability and the way to market in the field of biomedical research  Hosting biomedical enterprises Basic Research Clinical Reseach Valorization and Innovation Transfer to product developers
  • 15. Biopole: 15.400 m2 Medical Faculty & Management area: 13.500m2 Medical Care area: 166.400 m2 22
  • 16. SME/ IIS La Fe Partnership
  • 17. IDEA / PRODUCT
  • 18. CRUnit (biomedicalcontract researchUnit)
  • 19. PLATFORMS The IIS La Fe offers scientific and technological services with more than 10,000 m2 of clinical and research laboratories CRUnit Omic Platform Genomics Cytomics Analitycal Unit Biomedical Research Support Pre-Clinical Toxicity Platform Cell Culture Models Animal Models Clinical Genetic Platform Pharmacogenetics Cytogenetic Analysis Genetic Anlysis
  • 20. PRE-CLINICAL TOXICITY PLATFORM Cell Culture Models cellculture_toxicity@iislafe.es Genotoxicity Hepatotoxicity Phototoxicity Animal Models animalmodel_toxicity@iislafe.es Drug and Food Toxicity Ecotoxicity Coordinates preclinical or environmental studies in different levels of complexity from in vitro cellular models to animal models for a wide variety of toxicological studies. The know-how and validated systems generated indoors are of great value in order to provide with high quality experimental designs and accurate and reliable results promoting fast decision-making
  • 21. RESEARCH OMIC PLATFORM Genomics genomics@iislafe.es Arrays arrays_service@iislafe.es Genotiping and Sequencing Cytogenetics Cytomics cytomics@iislafe.es Analytical Unit analytical_unit@iislafe.es Metabolics/MS Proteomics It is a powerful platform for the analysis, validation and interpretation of massive data sets Merges a set of high-tech disciplines such as Genomics, Cytomics, Metabolomics and Proteomics.
  • 22. Offers a customised global GLP service: - including analytical services, - consultancy, as well as - the development of analytical methods Request study Tailored design Resultsin compliance with regulation Quickproblem solving Fast-decisionmaking CUSTOMERNEEDS
  • 23. Enzymatic activities Biomarkers Metabolomic profile Secondary metabolism compounds Signal transduction molecules Target molecules from biotransformation processes Expertise and professionals at your disposal for a wide variety of analytical determinations in compliance with GLP principles:
  • 24. IDEA / PRODUCT Stock Options or Shares, Capital return Costs paid in valorization Procces
  • 25. SHARING FUTURE VALUE
  • 26. www.iislafe.es

×